Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis
- PMID: 22761458
- PMCID: PMC6287505
- DOI: 10.1210/jc.2012-1538
Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis
Abstract
Context: Müllerian inhibiting substance (MIS) is produced in Sertoli cells of fetal testis and causes regression of müllerian ducts in male embryos. MIS also can induce the cell cycle arrest and apoptosis in müllerian duct-derived tumors in vivo and in vitro.
Objective: Our objective was to investigate the expression of MIS type II receptor (MISR II) and whether MIS can inhibit the proliferation and induce apoptosis in primary cultures of endometrial stromal cells (ESC) of endometriosis.
Design and settings: In vitro experiments were performed in the university research laboratory.
Participants: Tissue samples from 12 patients who had undergone evisceration for ovarian endometrial cysts were included in this study.
Interventions and main outcome measures: The expression of MISR II in ESC was investigated by immunohistochemistry. The cell viability and apoptosis in ESC treated with MIS was measured by methylthiazoletetrazolium assay and annexin V analysis. The expression of regulatory proteins in ESC treated with MIS was shown by Western blotting.
Results: ESC showed specific immunostaining for the MISR II. ESC treated with MIS exhibited 32% growth inhibition (P = 0.0001). The changes in cell cycle distribution after MIS exposure at 72 h demonstrated that S and G(2)M phases were decreased; G(0)G(1) and sub-G(0)G(1) phases were increased. ESC treated with MIS showed 13.72% annexin V-fluorescein isothiocyanate positivity. In the ESCs, which contain defective p16, MIS increased the expression of pocket proteins p107 and p130 and decreased E2F transcription factor 1.
Conclusions: The results support a central role for MIS in endometriosis. Although the precise mechanism of MIS-mediated inhibition of ESC growth has not been fully defined, these data suggest that MIS has activity against ESC in vitro and may also be an effective targeted therapy for endometriosis.
Figures
Similar articles
-
Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.Int J Oncol. 2011 Oct;39(4):811-20. doi: 10.3892/ijo.2011.1042. Epub 2011 May 13. Int J Oncol. 2011. PMID: 21573503 Free PMC article.
-
Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.Int J Oncol. 2012 Jun;40(6):2013-21. doi: 10.3892/ijo.2012.1370. Epub 2012 Feb 14. Int J Oncol. 2012. PMID: 22344630 Free PMC article.
-
Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium.Fertil Steril. 2009 Apr;91(4):1195-203. doi: 10.1016/j.fertnstert.2008.01.028. Epub 2008 Mar 7. Fertil Steril. 2009. PMID: 18328480
-
Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.Mol Cell Endocrinol. 2003 Dec 15;211(1-2):37-42. doi: 10.1016/j.mce.2003.09.009. Mol Cell Endocrinol. 2003. PMID: 14656474 Review.
-
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors.Obstet Gynecol Sci. 2014 Sep;57(5):343-57. doi: 10.5468/ogs.2014.57.5.343. Epub 2014 Sep 17. Obstet Gynecol Sci. 2014. PMID: 25264524 Free PMC article. Review.
Cited by
-
High anti-Müllerian hormone (AMH) is associated with increased risks of ectopic pregnancy in women undergoing fresh embryo transfer cycle, a cohort study.Reprod Biol Endocrinol. 2023 Feb 3;21(1):18. doi: 10.1186/s12958-022-01038-6. Reprod Biol Endocrinol. 2023. PMID: 36737777 Free PMC article.
-
Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines.Yonsei Med J. 2016 Jan;57(1):33-40. doi: 10.3349/ymj.2016.57.1.33. Yonsei Med J. 2016. PMID: 26632380 Free PMC article.
-
Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue.Int J Mol Sci. 2019 Mar 15;20(6):1325. doi: 10.3390/ijms20061325. Int J Mol Sci. 2019. PMID: 30884769 Free PMC article.
-
Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue.Cells. 2020 Oct 17;9(10):2312. doi: 10.3390/cells9102312. Cells. 2020. PMID: 33080800 Free PMC article.
-
The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages.Oncotarget. 2017 Oct 7;8(59):99950-99965. doi: 10.18632/oncotarget.21556. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245952 Free PMC article.
References
-
- Vlahos NF , Kalampokas T , Fotiou S. 2010. Endometriosis and ovarian cancer: a review. Gynecol Endocrinol 26:213–219 - PubMed
-
- Dufournet C , Uzan C , Fauvet R , Cortez A , Siffroi JP , Daraï E. 2006. Expression of apoptosis-related proteins in peritoneal, ovarian and colorectal endometriosis. J Reprod Immunol 70:151–162 - PubMed
-
- Nasu K , Nishida M , Kawano Y , Tsuno A , Abe W , Yuge A , Takai N , Narahara H. 2011. Aberrant expression of apoptosis-related molecules in endometriosis: a possible mechanism underlying the pathogenesis of endometriosis. Reprod Sci 18:206–218 - PubMed
-
- Meresman GF , Vighi S , Buquet RA , Contreras-Ortiz O , Tesone M , Rumi LS. 2000. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 74:760–766 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical